CoreCivic Reports Strong Q3 2026 Growth Driven by Federal Demand and Facility Sales
CoreCivic (CXW) delivered robust third-quarter 2026 financial results, characterized by a 28.2% year-over-year increase in total revenue to $744.1 million. This growth was primarily fueled by heightened federal demand and the integration of Clinical Solutions Pharmacy. The company also realized significant capital from the sale of four detention facilities to the Department of Homeland Security, generating $1.6 billion in net proceeds. Operational efficiency improved significantly, with adjusted EBITDA rising 32.6% to $117.8 million. Management utilized strong cash flows to reduce debt by over $700 million and execute a $500 million share repurchase program, which reduced the weighted average share count by 13.8%. Following these results, CoreCivic raised its full-year guidance for both adjusted diluted EPS and normalized FFO.
Tickers: $CXW
Topics: EPS beat federal contracts operational expansion revenue growth